RMD Open
is an open access, peer-reviewed rheumatology journal that publishes original research on rheumatic and musculoskeletal disorders and connective tissue diseases
Impact Factor: 6.2
Citescore: 7.7
All metrics >>
Latest Articles
Vasculitis:
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register26 March 2024
Psoriatic arthritis:
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study26 March 2024
Vasculitis:
DWI scrolling artery sign for the diagnosis of giant cell arteritis: a pattern recognition approach22 March 2024
Video Abstract
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
Conclusions: Bimekizumab demonstrated a safety profile consistent with previous reports; no new safety signals were identified. Sustained efficacy was observed from weeks 16 to 52.
Find out moreAltmetrics
Most Read Articles
Autoimmunity:
Association between sinusitis and incident rheumatic diseases: a population-based study22 February 2024
Rheumatoid arthritis:
Hormonal and reproductive factors in relation to the risk of rheumatoid arthritis in women: a prospective cohort study with 223 526 participants9 January 2024
Rheumatoid arthritis:
Re-evaluating the mythical divide between traditional and novel cardiovascular risk factors in rheumatoid arthritis1 March 2024